ow component Merck (MRK) is among the companies reporting earnings this morning. The drugmaker beat on the bottom line, reporting adjusted earnings of 92-cents a share when estimates were for 88-cents. Sales however were a small miss at $11.03-billion versus $11.124-billion, and profits were actually down 35% on competition from generic drugs.
Biotech Biogen Idec (BIIB) also reported. It missed estimates on earnings, by a nickel a share at $2.05. Revenues were higher than expected at $1.8-billion compared to estimates of $1.78-billion.
Burger King (BKW) also missed on the bottom line by 2-cents with earnings of 19-cents. Revenues however were higher than the consensus at $275.1-million versus $266.59-million. The chain credits climbing same-store sales overseas. Read more.
No comments:
Post a Comment